SemaThera Inc

SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targets the 30% DME patients who are poor responders to current anti-VEGF therapies.

Website: semathera.com

Employees: 5 - 9

HQ: N/A

Location: Westmount, QC, CA

Revenue: Not Available

diabetic macular edema ocular diseases semaphorin 3A

SemaThera Inc Technologies

Email Providers

Outlook

CMS

WordPress.org

Fonts

Google Font API

Hosting

Google Cloud Hosting

Other

Mobile Friendly

View All Technologies Used At SemaThera Inc

Similar companies to SemaThera Inc

Remedium AI SyntBioLab Inc. Biopra Cité de la Biotech / Biotech City Altius Healthcare Inc. Molecular Forecaster ELECTRO-MEDIC Au centre des Arts; Soins thérapeutiques bacterras Inc IniXium Saintrino Technologies Periowave Dental Technologies Inc. HANDS that SEE massage studio Idunn Technologies Laboratoires MZL AllGaea Abnatura Saguaro Technologies Clinique Sport Sante Laurentides Therillia Development Company Inc.

Contacting SemaThera Inc: Connect with Executives and Employees

Get in Touch with SemaThera Inc Executives and Employees

Connecting with SemaThera Inc's Executives and Workforce

Accessing Contact Information for SemaThera Inc Executives

Connecting with SemaThera Inc: Reach Out to Their Team

Discover How to Contact SemaThera Inc Executives and Staff

Looking to connect with SemaThera Inc executives or employees?

Seeking to Get in Touch with SemaThera Inc Executives or Staff?

Want to Reach Out to SemaThera Inc Executives or Team Members?

In Search of Contact Details for SemaThera Inc Professionals?

Connecting with SemaThera Inc: Contacting Executives and Staff

Browse companies

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z